Nasdaq agrx.

PRINCETON, N.J., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company, today announced positive top-line results from its ...PRINCETON, N.J., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, announced a positive outcome from today’s meeting of the Bone ...Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.Find the latest press releases from Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.

Nov 19, 2023 · NASDAQ:AGRX opened at $2.06 on Friday. The stock has a market capitalization of $5.17 million, a P/E ratio of -0.15 and a beta of 1.81. The company has a 50 day moving average price of $1.96 and a 200 day moving average price of $2.79. Agile Therapeutics has a fifty-two week low of $1.65 and a fifty-two week high of $16.00. Stock Symbol NASDAQ:AGRX. Total Funding Amount $240.8M. Total Funding Amount . Unlock for free . Contacts 32. Employee Profiles 7. Investors 12. Similar Companies 25. Recent News & Activity. News • Oct 4, 2023. GlobeNewswire News Room — Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under …

Shares of NASDAQ AGRX opened at $2.16 on Friday. Agile Therapeutics has a one year low of $1.65 and a one year high of $16.00. The firm has a market …PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of ...

The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”Find the latest Financials data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”PRINCETON, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that its Board of Directors declared a dividend of one one ...

PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla ...

On Mar. 31, he reported buying 10,000 shares at an average price of $20.17. This case of insider buying is a personal investment of over $200,000. Wall Street also thinks that the shares are ...

PRINCETON, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today applauded House Congressional Committee leaders in urging the ...November 20, 2023 at 1:14 PM PST. Listen. 1:51. The Nasdaq 100 Stock Index closed at the highest in nearly two years, with tech stocks gaining on high expectations for artificial …Nasdaq provides the ownership stake information in a company, including the number of shares held by those institutions in a firm, along with recent purchases and sales information. Institutional ...PRINCETON, N.J., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering of ...EQS-News: Agile Therapeutics, Inc. NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022 21.10.2022 / 17:00 CET/CEST The issuer is solely responsible for the...PRINCETON, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq: AGRX), a women’s healthcare company, today announced that on January 9, 2019 it received final meeting ...

Nov 9, 2023 · PRINCETON, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three and nine months ended ... PRINCETON, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has ...PRINCETON, N.J., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported financial results for the three months and year ended ...PRINCETON, N.J., July 28, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report second quarter 2022 financial results after ...Nov 19, 2023 · NASDAQ:AGRX opened at $2.06 on Friday. The stock has a market capitalization of $5.17 million, a P/E ratio of -0.15 and a beta of 1.81. The company has a 50 day moving average price of $1.96 and a 200 day moving average price of $2.79. Agile Therapeutics has a fifty-two week low of $1.65 and a fifty-two week high of $16.00. The extension notice from Nasdaq has no immediate effect on the listing or trading of the Company’s shares, which will continue to trade on the Nasdaq Capital Market under the symbol “AGRX.”Find the latest Revenue & EPS data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.

Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...

Jun 28, 2022 · Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ... The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current trading symbol "AGRX."PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of ...Apr 10, 2023 · The Company’s common stock will open for trading on the Nasdaq Capital Market on Tuesday, April 11, 2023 on a split-adjusted basis under the current trading symbol "AGRX." Records 1 - 18 of 20 ... Find the latest historical data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.Agile Therapeutics Inc (NASDAQ: AGRX ) ... The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on ...Apr 28, 2023 · PRINCETON, N.J., April 28, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced preliminary expectations for first quarter 2023 Twirla ... Agile Therapeutics Inc (NASDAQ:AGRX) shares are down by over 99% in the last year and down almost 72% in the last three months. As of this writing, Agile Therapeutics shares are trading at above $0.38 (52-week range of $0.37 to $50.40), giving it a market capitalization of more than $15 million.PRINCETON, N.J., Dec. 22, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women’s healthcare company, today announced that the U.S. Food and Drug Administration (FDA) issued ...

Apr 19, 2022 · Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...

Real time Agile Therapeutics (AGRX) stock price quote, stock graph, news & analysis.

Agile Therapeutics, Inc. (NASDAQ:AGRX) Q4 2022 Earnings Call Transcript (Insider Monkey) Mar-23-23 12:49PM Q4 2022 Agile Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)-9.33%. Mar-22-23 04:05PM Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update ...(NASDAQ: AGRX) forecast ROE is N/A, which is considered weak. What is AGRX's Price Target? According to 2 Wall Street analyst s that have issued a 1 year AGRX price target, the average AGRX price target is $8.50 , with the highest AGRX stock price forecast at $12.00 and the lowest AGRX stock price forecast at $5.00 .PRINCETON, N.J., May 18, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women’s healthcare company, today announced the content of the official minutes from its Type A ...Find the latest Financials data for Agile Therapeutics, Inc. Common Stock (AGRX) at Nasdaq.com.On Mar. 31, he reported buying 10,000 shares at an average price of $20.17. This case of insider buying is a personal investment of over $200,000. Wall Street also thinks that the shares are ...AGRX Agile Therapeutics Inc Current Report Filing (8-k) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under ...The Nasdaq is up 3,719.01 points, or 35.5%. The Russell 2000 is up 120.77 points, or 6.9%. The Associated Press is an independent global news organization …The latest price target for . Agile Therapeutics (NASDAQ: AGRX) was reported by Maxim Group on September 22, 2023.The analyst firm set a price target for $5.00 expecting AGRX to rise to within 12 ...AGRX Sales Forecast. Next quarter’s sales forecast for AGRX is $9.20M with a range of $9.20M to $9.20M. The previous quarter’s sales results were $6.66M. AGRX beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.22% of the time in the same period.Agile Therapeutics, Inc. Common Stock (AGRX) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets.Follow. PRINCETON, N.J., March 21, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2022 ...

The latest price target for . Agile Therapeutics (NASDAQ: AGRX) was reported by Maxim Group on September 22, 2023.The analyst firm set a price target for $5.00 expecting AGRX to rise to within 12 ...Women’s Healthcare Company Agile Therapeutics Says It Believes It Has An Effective Business Plan In Place For Growth And Generating Positive Cash Flow - Agile Therapeutics (NASDAQ:AGRX), Dare ...(NASDAQ: AGRX) current product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without ...Instagram:https://instagram. financial planning software companiesspecial dividend announcements 2023how do i invest in blockchain technologybezinga pro PRINCETON, N.J., June 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Twirla will become available to MMCAP Infuse Members ... top pharmaceutical stocksplatforms to day trade Cash Expected to Enable Company to Fund Operations into Second Quarter 2019. PRINCETON, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women’s healthcare ...AGRX tried to move up and failed, broke the support level yesterday, and is now trading below it. Our idea is to take AGRX if it breaks the $ 1.97 price for further dec Hi traders, The consumer sector has been in a sharp decline in recent days and we have a trading idea in AGRX for further declines. AGRX tried to move up and failed, broke the ... stock movers of the day Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total ...PRINCETON, N.J., Jan. 02, 2020 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the appointment of Kimberly Whelan as Vice President of ...PRINCETON, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Twirla will become available through FPA Women’s ...